Technical Analysis for GUD - Knight Therapeutics Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Earnings Movers | Other | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Fell Below 20 DMA | Bearish | 2.14% | |
Fell Below 200 DMA | Bearish | 2.14% | |
MACD Bearish Signal Line Cross | Bearish | 2.14% | |
Expansion Breakdown | Bearish Swing Setup | 2.14% | |
Expansion Pivot Sell Setup | Bearish Swing Setup | 2.14% | |
Volume Surge | Other | 2.14% | |
Wide Range Bar | Range Expansion | 2.14% | |
Earnings Movers | Other | 2.14% |
Alert | Time |
---|---|
Rose Above Lower Bollinger Band | 2 days ago |
Up 2% | 2 days ago |
Up 1% | 2 days ago |
3x Volume Pace | 2 days ago |
Expansion Pivot Sell Entry | 2 days ago |
Get this analysis on your stocks daily!
- Earnings date: 2024-11-07
Knight Therapeutics Inc. Description
Knight Therapeutics Inc is a Canada-based pharmaceutical company. The Company is engaged in developing, acquiring, in-licensing, out-licensing, marketing and distributing pharmaceutical products, consumer health products and medical devices in Canada and select international markets. It finances other life sciences companies in Canada and internationally. Its prescription pharmaceuticals and medical devices in various stages of development include Impavido, AzaSite, ATryn, Photofrin, ILUVIEN, TULSA-PRO, PROBUPHINE, Advaxis Family of Products, Ember Family of Products, NeurAxon Family of Products, Antibe Family of Products, Blood Factor Products and VEWS Vascular Early Warning System. In addition, the Company also has a portfolio of branded consumer health products, including Neuragen, Flat Tummy Tea, FOCUSFactor, FLEXISEQ, SEQuaderma, HandMD, UrgentRx, Laboratoire Dr. Renaud, Premiology and Pro-Derm.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Marketing Pharma Pharmaceutical Labor Science Pharmaceuticals Life Sciences Pharmaceutical Products Pharmaceutical Industry Medical Devices Pharmaceutical Sciences Consumer Health Products Pharmaceutical Industry In China
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 6.23 |
52 Week Low | 4.61 |
Average Volume | 76,876 |
200-Day Moving Average | 5.672 |
50-Day Moving Average | 5.755 |
20-Day Moving Average | 5.602 |
10-Day Moving Average | 5.573 |
Average True Range | 0.161 |
RSI (14) | 34.21 |
ADX | 20.97 |
+DI | 12.502 |
-DI | 33.918 |
Chandelier Exit (Long, 3 ATRs) | 5.466 |
Chandelier Exit (Short, 3 ATRs) | 5.584 |
Upper Bollinger Bands | 5.888 |
Lower Bollinger Band | 5.316 |
Percent B (%b) | -0.1 |
BandWidth | 10.225 |
MACD Line | -0.091 |
MACD Signal Line | -0.060 |
MACD Histogram | -0.0312 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 5.530 | ||||
Resistance 3 (R3) | 5.507 | 5.393 | 5.485 | ||
Resistance 2 (R2) | 5.393 | 5.325 | 5.405 | 5.470 | |
Resistance 1 (R1) | 5.327 | 5.282 | 5.360 | 5.350 | 5.455 |
Pivot Point | 5.213 | 5.213 | 5.230 | 5.225 | 5.213 |
Support 1 (S1) | 5.147 | 5.145 | 5.180 | 5.170 | 5.065 |
Support 2 (S2) | 5.033 | 5.102 | 5.045 | 5.050 | |
Support 3 (S3) | 4.967 | 5.033 | 5.035 | ||
Support 4 (S4) | 4.990 |